Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
B&G Foods
BGS
$294M
| $658K | ﹤0.01% |
+66,500
| New | +$825K |
|
|
EGIO
2577
DELISTED
Edgio, Inc. Common Stock
EGIO
| $658K | ﹤0.01% |
19,299
+6,218
| +48% | +$195K |
|
|
AFBI
2578
DELISTED
Affinity Bancshares
AFBI
| $657K | ﹤0.01% |
44,404
-2,996
| -6% | -$41.8K |
|
2579
Capital Group International Focus Equity ETF
CGXU
$6.63B
| $657K | ﹤0.01% |
30,200
-26,800
| -47% | -$616K |
|
2580
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.23B
| $656K | ﹤0.01% |
22,500
-1,200
| -5% | -$33.9K |
|
|
LENZ
2581
LENZ Therapeutics
LENZ
$149M
| $656K | ﹤0.01% |
37,771
+2,900
| +8% | +$50.4K |
|
|
MCHB
2582
Mechanics Bancorp
MCHB
$3.78B
| $655K | ﹤0.01% |
84,100
-276,800
| -77% | -$2.46M |
|
|
NSA
2583
DELISTED
National Storage Affiliates Trust
NSA
| $654K | ﹤0.01% |
20,600
-63,100
| -75% | -$2.14M |
|
2584
Passage Bio
PASG
$14.8M
| $654K | ﹤0.01% |
49,720
+765
| +2% | +$12.6K |
|
2585
Coeur Mining
CDE
$19.3B
| $653K | ﹤0.01% |
+294,095
| New | +$767K |
|
|
DOG
2586
ProShares Short Dow30
DOG
$87.3M
| $653K | ﹤0.01% |
19,600
-6,000
| -23% | -$194K |
|
|
JBTM
2587
JBT Marel
JBTM
$6.23B
| $652K | ﹤0.01% |
+6,200
| New | +$694K |
|
2588
Minerva Neurosciences
NERV
$219M
| $650K | ﹤0.01% |
94,200
-4,100
| -4% | -$36.7K |
|
|
NAGE
2589
Niagen Bioscience
NAGE
$239M
| $650K | ﹤0.01% |
444,912
-15,627
| -3% | -$24.4K |
|
2590
Asure Software
ASUR
$245M
| $649K | ﹤0.01% |
68,600
-12,973
| -16% | -$157K |
|
2591
LifeMD
LFMD
$166M
| $649K | ﹤0.01% |
103,800
+23,829
| +30% | +$103K |
|
2592
ImmuCell
ICCC
$90.9M
| $648K | ﹤0.01% |
121,380
-1,009
| -0.8% | -$5.12K |
|
2593
UTStarcom
UTSI
$23.5M
| $648K | ﹤0.01% |
172,226
-23,700
| -12% | -$87K |
|
2594
Neurogene
NGNE
$723M
| $646K | ﹤0.01% |
40,862
-5,999
| -13% | -$88.6K |
|
2595
Vanguard ESG International Stock ETF
VSGX
$6.83B
| $646K | ﹤0.01% |
12,800
-32,800
| -72% | -$1.73M |
|
2596
iShares Global Tech ETF
IXN
$9.42B
| $642K | ﹤0.01% |
11,100
+500
| +5% | +$30.4K |
|
|
SSKN
2597
DELISTED
Strata Skin Sciences
SSKN
| $642K | ﹤0.01% |
107,915
-1,400
| -1% | -$10.8K |
|
2598
S&T Bancorp
STBA
$1.8B
| $641K | ﹤0.01% |
23,688
-812
| -3% | -$23.5K |
|
2599
Zevra Therapeutics
ZVRA
$672M
| $640K | ﹤0.01% |
132,700
+800
| +0.6% | +$3.99K |
|
|
ML
2600
DELISTED
MoneyLion Inc.
ML
| $640K | ﹤0.01% |
29,563
+10,700
| +57% | +$177K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.